NCT05496270View on ClinicalTrials.gov

Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer

CompletedOBSERVATIONAL
Enrollment

1,509

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2019

Study Completion Date

August 31, 2022

Conditions
Rectal Cancer
Interventions
PROCEDURE

total mesorectal excision

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT05496270 - Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer | Biotech Hunter | Biotech Hunter